<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01276002</url>
  </required_header>
  <id_info>
    <org_study_id>UKSH-122010</org_study_id>
    <nct_id>NCT01276002</nct_id>
  </id_info>
  <brief_title>Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.</brief_title>
  <acronym>Disduct</acronym>
  <official_title>Randomized Multicenter Study on Pancreatic Duct Stenting in Disrupted or Obstructed Ducts in Context With Endoscopic Treatment of Pancreatic Pseudocysts.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The disruption of the pancreatic duct seems to be a major cause pseudocyst formation and
      persistence in patients suffering from acute/chronic pancreatitis. No prospective randomized
      studies have been conducted on the influence of pancreatic duct stenting for the patients`
      benefits and recurrence rates. The aim fo this study is therefore to evaluate prospectively
      in a randomized, controlled fashion in patients wit pancreatic pseudocysts, wether pancreatic
      duct stenting of a disrupted pancreatic duct is beneficial in terms of quicker clinical
      recovery and avoidance of recurrence of pancreatic pseudocysts.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of pancreatic pseudocyst</measure>
    <time_frame>two years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Chronic Acute Pancreatitis</condition>
  <arm_group>
    <arm_group_label>No stenting</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group, no stenting of the pancreatic duct in case of a disrupted duct</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pancreatic duct stenting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in case of a disrupted pancreatic duct, patients will undergo pancreatic duct stenting in this arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pancreatic duct stenting</intervention_name>
    <description>in case of a disrupted pancreatic duct, patients will undergo pancreatic duct stenting.</description>
    <arm_group_label>Pancreatic duct stenting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pancreatic pseudocyst, at least 6 cm in diameter

          -  symptomatic pancreatic pseudocyst

          -  increasing size of pancreatic pseudocyst within 6 weeks

        Exclusion Criteria:

          -  Pregnancy

          -  Age less than 18 years

          -  Postoperative status preventing access to papilla

          -  Allergy to contrast preventing from ERP

          -  Missing informed consent to study

          -  PTT above 1.5 times of normal, unless substituted

          -  Platelet count less than 50.000/Âµl, unless substituted

          -  Pancreatic ascites or fistula

          -  Life expectancy less than 2 years

          -  Percutaneously drained cysts are not part of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Ellrichmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Annette Fritscher-Ravens, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mark Ellrichmann, MD</last_name>
    <phone>+494315972075</phone>
    <email>mark.ellrichmann@uk-sh.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Annette Fritscher-Ravens, MD, PhD</last_name>
    <phone>+494315972075</phone>
    <email>fri.rav@btopenworld.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Interdisciplinary Endoscopy, University hospital Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Ellrichmann, MD</last_name>
      <phone>+494315972075</phone>
      <email>mark.ellrichmann@uk-sh.de</email>
    </contact>
    <contact_backup>
      <last_name>Annette Fritscher-Ravens, MD, PhD</last_name>
      <phone>+494315972075</phone>
      <email>fri.rav@btopenworld.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mark Ellrichmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 12, 2011</study_first_submitted>
  <study_first_submitted_qc>January 12, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2011</study_first_posted>
  <last_update_submitted>December 4, 2015</last_update_submitted>
  <last_update_submitted_qc>December 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Mark Ellrichmann</investigator_full_name>
    <investigator_title>Head Interdisciplinary Endoscopy</investigator_title>
  </responsible_party>
  <keyword>disrupted duct</keyword>
  <keyword>pancreatic pseudocysts</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Pancreatic Pseudocyst</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

